Kiora Pharmaceuticals (KPRX) Research & Development (2014 - 2026)
Kiora Pharmaceuticals (KPRX) reported Research & Development of $2.08 million for Q2 2026, down 19.8% from $2.59 million a year earlier and down 2.2% from the prior quarter.
Powered by 
Analysis
Kiora Pharmaceuticals (KPRX) Research & Development (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Kiora Pharmaceuticals' Research & Development came in at $9.86 million, up 6.8% year-over-year; for FY2025, it came in at $10.78 million, up 37.5% from FY2024.
- Research & Development has increased for three consecutive years, with a five-year compound annual growth rate of 24.8% (FY2020 to FY2025).
- By year, Research & Development came in at $7.84 million in FY2024 (+94.7%), $4.03 million in FY2023 (+16.8%), $3.45 million in FY2022 (-35.5%) and $5.35 million in FY2021 (+50.0%).
- The Q2 2026 figure ranks as the lowest quarterly Research & Development since Q4 2024.
- Year over year, Research & Development gained in six of the last eight quarters, with growth averaging 36.6%.
- The high point for year-over-year Research & Development in five years was Q1 2024 (growth of 284.3%); the low point was Q2 2022 (a decline of 60.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $2.12 million (Q1 2026), $2.93 million (Q4 2025) and $2.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Kiora Pharmaceuticals | 14.34 Mn | -52.98 Mn | - | 2.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.08 Mn |
| Mar 31, 2026 | 2.12 Mn |
| Dec 31, 2025 | 2.93 Mn |
| Sep 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 2.59 Mn |
| Mar 31, 2025 | 2.53 Mn |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 1.39 Mn |
| Mar 31, 2023 | 438,283.00 |
| Dec 31, 2022 | 841,617.00 |
| Sep 30, 2022 | 1.33 Mn |
| Jun 30, 2022 | 567,227.00 |
| Mar 31, 2022 | 707,928.00 |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 1.63 Mn |
API Access
Kiora Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=KPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "KPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=KPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();